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Abstract Psoas muscle spasticity is hypothesised as a rare
cause of low back pain in patients with infantile cerebral
palsy. The authors describe a new manoeuvre for the study
of psoas tenderness and ultrasound (US)-guided transab-
dominal botulinum toxin injection technique. A possible
causal relationship between psoas tension and low back
pain was found incidentally in two examined cases. In
subsequent patients, botulinum toxin was injected and, in
cases of disappearance of symptoms, the psoas tendon was
sectioned at the pelvic brim with definitive disappearance
of pain. The relationship between psoas tension and low
back pain in patients with infantile cerebral palsy seems
likely, given the result in the four patients.
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Introduction
Clinically, patients with infantile cerebral palsy some-
times present with severe low back pain and a pressing
request for reduction of painful symptoms. A causal rela-
tionship between low back pain and psoas spasticity is
hypothesised. Effective spasticity treatment allows lower-
ing of tension and thus an altered lumbosacral posture.
Anatomic and functional aspects
The iliopsoas muscle is composed of the psoas and iliacus
muscle [1]. These two portions, which are clearly separat-
ed cranially, join together caudally and are both inserted
in the lesser femoral trochanter. Interest is focused on the
psoas muscle.
The psoas muscle is fusiform, elongated and extend-
ing from the lumbar region to the lesser trochanter. It is
proximally inserted in the groove formed by vertebral
bodies and their transverse processes (vertebral–costi-
form angle). Through a series of medially concave fibrous
arches, its anterior fibres are inserted in the anterior and
lateral surfaces of D12 to L5 intervertebral disks, while
posterior fibres originate from the 12th rib and from cos-
tiform processes of the first four lumbar vertebrae. The
psoas muscle thus forms a fusiform muscular body with
maximum thickness at the level of the sacroiliac joint.
Then it passes through the lumbar region and the pelvis,
emerging from this, below, through a groove on the ante-
rior border of the iliac bone between the anterior-inferior
iliac spine and the iliopectineal eminence. It is inserted in
the posterior surface of the lesser trochanter through a
strong tendon originating above, in the pelvis, on the mus-
cle’s posterior surface.
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psoas major and minor muscle, namely: ilioinguinal,
femorocutaneous, genitofemoral, obturator and femoral.
The psoas muscle acts as flexor of the hip, also induc-
ing external rotation and adduction. In the erect position,
it acts as flexor of the trunk forward.
In patients with infantile cerebral palsy, especially in
tetraparesis or paraparesis (diplegia), psoas muscle spas-
ticity may cause hip flexion deformity and a hollow back,
either dynamic or structured, i.e., caused by spastic con-
traction or fixed retraction of the muscle [2, 3]. After
causing these deformities, muscle tension may cause pain
in a still unknown way.
Materials and methods
Four patients (age range 6–21 years) with symptomatic low
back pain and CP diplegia or tetraparesis are described.
These patients are part of research on botulinum toxin
treatment approved by the ethical board of the Gaslini
Institute, following the Declaration of Helsinki. All the
patients and their parents were informed of the treatment
and gave their written consent.
In the first two patients, only clinical observations of a
“normal” treatment were made. These observations were
used to treat the last two patients; they were included in the
study for the presence of the following criteria: cerebral pal-
sied patients; persistent low back pain, unresponsive to every
treatment; positivity to the psoas tenderness manoeuvre.
Numerical Rating Scale (NRS) in the 0–10 version [4] is
used to measure pain preoperatively and in the follow-up.
Thomas test
This test is used to detect a hip flexion deformity and/or
contracture [5]. The patient is supine with the legs free out-
side the bed. The examiner places one hand behind the
small of the patient’s back, between it and the couch. There
is a small gap here due to normal lumbar lordosis. The exa-
miner abolishes the lumbar lordosis by flexing one patient’s
hip and feels the lumbar spine flatten out onto his hand.
When the lumbar spine is flat, if the patient’s other (studied)
hip is lifted off the bed, that is due to a deformity/contrac-
ture. The entity of the deformity/contracture is measured by
the angle of hip flexion between the bed and the thigh.
Staheli test
The “prone hip extension test” is described by the author
as a simple, convenient and reliable method of measur-
ing hip flexion contracture in spastic patients [6]. The
patient is prone with the lower limbs free outside the
bed. One examiner’s hand is on the sacrum to feel its
horizontal position; the second examiner’s hand lifts the
lower limb of the studied hip until the sacrum begins to
move up. The angle between the lifted lower limb and
the horizontal plane is measured to quantify the hip flex-
ion contracture.
Manoeuvre for the study of psoas tenderness
The patient is supine with hips and knees flexed at 90°, if
necessary with the legs slightly supported by the examin-
er, and is asked to bend one hip against resistance (iso-
metric contraction). The manoeuvre is positive if the
patient then suffers low back pain.
Ultrasound (US)-guided transabdominal botulinum toxin
injection technique for the psoas muscle 
The patient is sedated and in the supine position (Fig. 1).
US examination of the abdomen is performed with a
5–7.5 MHz linear probe (Hitachi, Tokyo, Japan), dis-
placing the intestinal loops medially starting from the
paramedian lower quadrants. Visualisation of vertebral
bodies and major iliac vessels serve as a reference.
Lateral to the spine, the body of the psoas muscle is
visualised and identified thanks to its movement, which
is synchronous during hip flexion–extension. A needle
of adequate length is used and botulinum toxin is dilut-
ed with at least 2 ml of saline solution. The drug is
injected in 4 sites, starting caudally or paraumbilically
with US visualisation of liquid flow coming out of the
needle.
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Fig. 1 US-guided transabdominal botulinum toxin injection technique
for the psoas muscleCase series
This study was started on the basis of clinical observa-
tions of the patients described below.
Case 1
Case 1 was a male, aged six years, suffering from spastic
tetraparesis. He walked with a rollator. The child was ad-
mitted to our unit because of frequent low back pain
(NRS = 6). Blood tests, X-ray of lumbar spine and neuro-
physiologic evaluation were performed and all results
were normal. Repeated clinical examinations showed
hypertonus of hamstrings, slight flexion of hips due to
psoas tension (10° at Thomas manoeuvre and 0° at Staheli
manoeuvre bilaterally) and adductor spasticity. Botu-
linum toxin (Botox, Allergan Pharmaceuticals, Westport,
Ireland) was injected into the hamstrings and hip adduc-
tors (50 U for each muscle per 17 kg of body weight). At
45 days postinjection, his hip flexion deformity had
decreased (< 5° at Thomas manoeuvre) and, most of all,
there was complete regression of pain (NRS = 0). This
had not reappeared 2 years after our drug administration.
Psoas relaxation and pain regression were not imme-
diately related, as botulinum toxin was injected into sev-
eral other muscles. However, since pelvic posture change
was clearly observed, a relationship between botulinum
injection, iliopsoas relaxation and disappearance of pain
was later hypothesised. The other cases reported here
seem to confirm this assumption.
Case 2
Case 2 was male, aged 18 years, with spastic diplegia with
considerable right prevalence. The right hip was flexed
(10° on the right side during Thomas and Staheli manoeu-
vres) and adducted. The right knee was flexed (–15°) and
the right foot presented equinus deformity (–5°). After
accurate orthopaedic and physiatric evaluation assisted by
gait analysis, bilateral psoas release at the pelvic brim [7, 8]
and correction of equinus deformity (according to Bau-
mann [9]) were performed. In the postoperative period, the
hip and foot deformities disappeared and after adequate
physiotherapy the gait improved considerably. Low back
pain (NRS = 5, referred after surgery), which had been
present for about two years and had not been mentioned by
the patient before surgery, regressed completely (NRS = 0).
This was such a change for this patient and the parents that
the result was described to us as ‘a major change’.
The two cases described above focused the attention
of the clinicians on the association between psoas tension
and low back pain with regression of pain after surgery-
or even drug-induced muscle relaxation.
Case 3
Case 3, a 12-year-old girl, suffered from spastic tetrapare-
sis. She was only able to walk at home using a rollator.
The girl had already been operated on in another institu-
tion at 7 years of age with bilateral myofascial lengthen-
ing of hamstrings and transfer of rectus femoris to semi-
tendinosus. Notwithstanding her obvious hip flexion,
psoas release at the pelvic brim had not been performed as
it was considered contraindicated in the overall therapeu-
tic programme. The girl was admitted to the unit at 10
years of age for severe low back pain (NRS = 7) prevent-
ing her from obtaining regular rest or effective physio-
therapy and occasionally even walking. At that time she
was diagnosed as suffering from an inflammatory disease
affecting the sacroiliac joints. Her pain did not disappear
in spite of administration of adequate anti-inflammatory
therapy, and was characterised by alternating regression
and acute phases, but generally presented a worsening
trend. At 12 years of age, the girl was readmitted to the
unit because of very severe back pain (NRS = 9) prevent-
ing rest and almost completely preventing walking and
standing.
Examination showed bilateral 20° hip flexion (both
with Thomas and Staheli manoeuvres). Botulinum toxin
(Botox, Allergan Pharmaceuticals, Westport, Ireland) at
high dosage (200 U per side per 42 kg of body weight)
was injected to the right and left psoas muscles. On the
following day, the girl reported complete disappearance
of her low back pain (NRS = 1).
After 15 days, when favourable results from her botu-
linum toxin injections were expected, pain reappeared
with the same intensity (NRS = 8).
Therefore bilateral psoas muscle release at the pelvic
brim [7, 8] was performed. At postoperative visits after
1.5, 6 and 12 months, respectively, the girl reported no
pain (NRS = 0) and, after a period of initial instability,
some gait improvement. Clinical observation showed
improvement of hip flexion (10° bilaterally on Thomas
and Staheli manoeuvres).
Case 4 
Case 4 was a 21-year-old man suffering from a spastic-
dystonic tetraparesis, but with an autonomous gait. The
patient was admitted to the unit for severe low back pain
(NRS = 7) requiring anti-inflammatory drug treatment,
even by intravenous injections. This produced a poor result
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had been performed in another institution with negative
results. The first examination showed hip flexion (20° at
Thomas manoeuvre and 10° at Staheli manoeuvre bilater-
ally), and tenderness from the psoas tension (elicited by the
hip examination/manoeuvre described above). His gait pat-
tern showed a hollow back due to pelvic anteversion. Pain
reduced the patient’s ability to walk and to keep the erect
position. Botulinum toxin in right and left psoas with the
technique already described was injected. In this patient,
the drug administered (Botox, Allergan Pharmaceuticals,
Westport, Ireland, 200 U per side per 68 kg of body
weight) had a classic effect: after 15 days, the patient had
complete regression of pain (NRS = 0) and was well for 3
months. Then pain reappeared with the same intensity as
before (NRS = 7). Surgical psoas release was decided; this
brought about complete disappearance of painful symp-
toms (NRS = 0) and decreased hip flexion (10° at Thomas
manoeuvre and 5° at Staheli manoeuvre bilaterally). Pain
was absent even 12 months later.
Discussion
Muscle visualisation with the US technique described
above is optimal and botulinum injection in the correct
muscle portal is certain, which makes monitoring with a
myostimulator as suggested by Willenborg et al. [10]
unnecessary. In our clinical practice in children, posterior
access to the muscle is not feasible with CT monitoring
[11] because of concerns about exposure to radiation.
Techniques without instrumental monitoring [12] may fail
because of uncertain injection site access. An inguinal
injection route to the psoas muscle [13, 14] does not meet
our therapeutic needs as, through this portal, the drug is
injected only into the iliac muscle, as, at this level, the
psoas muscle is already tendinous.
Despite several examinations, in this series other
explanations of the patients’ low back pain were not
found. Particularly spasm of paraspinal muscles [15],
signs of dystonia [16], other neurological involvement
(central or peripheral), intrapelvic diseases or orthopaedic
problems (trauma, disk protrusion) were not found. The
origin of the pain from psoas muscle was only a clinical
observation in the first two cases. Only the other two real-
ly follow the presented theory. This is, with the small
number of cases, a limit for this series.
In the literature there are no publications showing a
relationship between psoas muscle and back pain in
patients with infantile cerebral palsy.
Though based on few patients, the theory correlating
psoas tension to low back pain seems to be validated by
the four cases described above.
In order to evaluate any possible iliopsoas role,
patients affected by cerebral palsy and low back pain
should be checked for the following features:
1. presence of continuing and severe (minimum NRS = 5)
low back pain in patients with infantile cerebral palsy
in whom any other spinal or intrapelvic diseases have
been excluded;
2. presence of hip flexion (positivity of Thomas and/or
Staheli manoeuvres);
3. positive manoeuvre for the study of psoas tenderness;
4. regression of pain after US-guided transabdominal
injection of botulinum toxin in the psoas muscle.
Only when these requirements are met, it is possible to
propose psoas tendon release at the pelvic brim [7, 8] to the
patient. The limit of this study, which is still in its initial
phase, is the small number of patients and the short follow-
up. These preliminary data, which can be considered based
only on clinical impressions, need to be confirmed by a larg-
er number of cases and a longer follow-up.
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